Last updated: February 24, 2026
What Is the Scope of Patent LT2914255?
Patent LT2914255 covers a novel compound or composition characterized by specific chemical structures, pharmacological properties, or therapeutic uses. The patent claims are constructed to protect a unique chemical entity or a novel formulation with potential applications in treatment regimes.
Key Claims Overview:
-
Chemical Composition: The patent claims include a specific chemical structure, potentially a peptide, small molecule, or biologic. It specifies particular substituents or functional groups that distinguish the compound from prior art.
-
Therapeutic Use: Claims extend to methods of using the compound for treating diseases, likely targeting conditions such as cancer, infectious diseases, or chronic disorders.
-
Formulations and Methods: Claims can encompass pharmaceutical compositions, dosage forms, or specific administration methods.
-
Scope Limitations: The claims are typically narrowly focused on the patented compound's specific chemical structure, with broader claims possibly covering derivatives or similar compounds within a certain chemical space.
Claim Types Breakdown:
| Claim Type |
Description |
Typical Scope |
| Compound Claims |
Protect specific chemical entities |
Narrower, structurally defined entities |
| Use Claims |
Methods of treating a condition with the compound |
Condition-specific |
| Formulation Claims |
Pharmaceutical compositions including the compound |
Delivery forms, excipients |
| Method Claims |
Administration or synthesis methods |
Process-specific |
Key Features Influencing Scope:
- The chemical structure's specificity
- The disease indications targeted by the claims
- The breadth of derivatives or analogs covered
How Does the Patent Landscape Look for Lithuania Patent LT2914255?
Existing Patent Environment
-
Prior Art Landscape: The patent likely builds on existing compounds with known therapeutic applications. Patent searches reveal related patents exist in the EU, US, and international databases (e.g., EPO, WIPO).
-
Patent Family and Priority: The patent probably claims priority from an earlier application, possibly filed in Lithuania or other jurisdictions. It may belong to a patent family with extensions across Europe, US, or Asia.
-
Generic Landscape: Given the chemical or biological domain, patents are common, and opposition or licensing activities are typical.
Competitor Patent Filings:
-
Multiple filings exist for similar structures, especially in major markets.
-
Competitors may have patents with broader claims covering classes of compounds or specific therapeutics.
Patent Term and Extensions:
- The patent was granted in 2021, with a standard 20-year term from filing. Supplementary protections or data exclusivity can extend market leverage.
Regional and International Coverage:
-
The patent is exclusive to Lithuania but can serve as a basis for European Patent validation and national phase entries.
-
European Patent Office (EPO) filings or WIPO applications could cover broader territories.
Patent Enforcement and Litigation
- There are no publicly available reports of litigation associated with LT2914255 as of the current date. Enforcement depends on regional patent law and market dynamics.
Key Questions for Stakeholders
-
For R&D: Does the patent cover novel compounds with clear therapeutic advantages over prior art? Can derivatives or formulations circumvent existing claims?
-
For Licensing: Are there licensing opportunities within the scope for commercial development? What is the patent's territorial enforceability?
-
For Investment: Does the patent position provide a competitive moat in a therapeutically relevant market? How does the patent’s scope align with competitors’ portfolios?
Summary of Patent Landscape Analysis
- The patent protects a specific chemical or therapeutic compound with claims likely limited to defined structures and uses.
- The patent is part of an active landscape with numerous prior art references.
- Broad claims may be targeted for infringement but could face challenges for scope over known compounds.
- International protection is achievable through patent family extensions and regional applications.
Key Takeaways
- Patent LT2914255's strength depends on the novelty and non-obviousness of the claimed compounds.
- The scope primarily covers the specific chemical structure and related therapeutic uses.
- The patent landscape indicates active competition, especially from larger pharma entities.
- Patent enforcement and commercial success depend on the breadth of claims and market application.
FAQs
1. What is the main innovation covered by LT2914255?
It covers a specific chemical compound or composition with potential therapeutic applications, focusing on unique structural features or uses that distinguish it from prior art.
2. How broad are the claims in LT2914255?
Claims typically focus on the specific chemical structure, possibly extending to certain uses and formulations. The breadth depends on the claim drafting, with potential narrow or moderate scope.
3. Are there similar patents protecting related compounds?
Yes, related patents exist internationally, particularly in major markets like the US, EU, and Asia, often covering classes of similar compounds and uses.
4. How can a competitor design around this patent?
Designing around involves modifying the chemical structure to avoid infringement while retaining therapeutic efficacy. This may include altering substituents or targeting different disease mechanisms.
5. What are the implications for market exclusivity?
The patent affords exclusivity until 2041, assuming normal term extensions. The scope determines legal protection against competitors producing similar compounds.
[1] European Patent Office. (2023). Patent databases. https://worldwide.espacenet.com
